The Ministry of Economy and Competitiveness of Spain has approved the research project submitted by INMUNOTEK SL to the programme RETOS-COLABORACIÓN 2015.
With a budget of 1,207,322 euros in three years, its objective is to develop a new cancer vaccine for several malignant tumours. Three research public entities participate in this project: the Experimental Unit from San Carlos Hospital (Madrid), the Dep. of Immunology and Cellular Biology (Complutense University of Madrid) and the Dep. of Chemical and Physical Biology (CIB-CSIC, Madrid)